Position in GLAS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,381,887
New position
Shares Held
106,299
first reported quarter
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $47,963,007 across 28 Drug Manufacturers - Specialty & Generic names. GLAS ranks #11 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
253,412 | $18,210,186 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
205,600 | $6,965,728 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
83,088 | $3,409,100 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,008 | $2,171,654 | |
| 5 | VTRS |
Viatris Inc
|
130,959 | $2,079,628 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
52,907 | $1,915,233 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
|
156,492 | $1,538,316 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
95,466 | $1,530,319 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,381,887 | 106,299 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||